{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:00Z","timestamp":1787020440302,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05279-9","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T11:07:14Z","timestamp":1742209634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Post-treatment transmissibility of Plasmodium falciparum infections: an observational cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Kassahun","family":"Habtamu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallelujah","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashenafi","family":"Abossie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assalif","family":"Demissew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arega","family":"Tsegaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teshome","family":"Degefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daibin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chieh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofa","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Kibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Kazura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyene","family":"Petros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delenasaw","family":"Yewhalaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"5279_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12936-020-03446-8","volume":"19","author":"G Rathmes","year":"2020","unstructured":"Rathmes G, Rumisha SF, Lucas TC, Twohig KA, Python A, Nguyen M, et al. Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991\u20132019. Malar J. 2020;19:374.","journal-title":"Malar J"},{"key":"5279_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1051\/parasite\/2018021","volume":"25","author":"M Ouji","year":"2018","unstructured":"Ouji M, Augereau J-M, Paloque L, Benoit-Vical F. Plasmodium falciparum resistance to artemisinin-based combination therapies: a sword of Damocles in the path toward malaria elimination. Parasite. 2018;25:24.","journal-title":"Parasite"},{"key":"5279_CR3","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.3390\/molecules25122773","volume":"25","author":"R Choi","year":"2020","unstructured":"Choi R, Michaels SA, Onu EC, Hulverson MA, Saha A, Coker ME, et al. Taming the boys for global good: contraceptive strategy to stop malaria transmission. Molecules. 2020;25:2773.","journal-title":"Molecules"},{"key":"5279_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002380","volume":"14","author":"J Hemingway","year":"2016","unstructured":"Hemingway J, Shretta R, Wells TN, Bell D, Djimd\u00e9 AA, Achee N, et al. Tools and strategies for malaria control and elimination: what do we need to achieve a grand convergence in malaria? PLoS Biol. 2016;14: e1002380.","journal-title":"PLoS Biol"},{"key":"5279_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12936-019-3032-3","volume":"18","author":"P Omondi","year":"2019","unstructured":"Omondi P, Burugu M, Matoke-Muhia D, Too E, Nambati EA, Chege W, et al. Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether\u2013lumefantrine or dihydroartemisinin\u2013piperaquine treatment. Malar J. 2019;18:398.","journal-title":"Malar J"},{"key":"5279_CR6","doi-asserted-by":"crossref","unstructured":"Barry A, Bradley J, Stone W, Guelbeogo MW, Lanke K, Ouedraogo A, et al. Increased gametocyte production and mosquito infectivity in chronic versus incident Plasmodium falciparum infections. medRxiv. 2020 (preprint).","DOI":"10.1101\/2020.04.08.20057927"},{"key":"5279_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/pathogens10030346","volume":"10","author":"J Chawla","year":"2021","unstructured":"Chawla J, Oberstaller J, Adams JH. Targeting gametocytes of the malaria parasite Plasmodium falciparum in a functional genomics era: next steps. Pathogens. 2021;10:346.","journal-title":"Pathogens"},{"key":"5279_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009672","volume":"15","author":"C Koepfli","year":"2021","unstructured":"Koepfli C, Nguitragool W, de Almeida ACG, Kuehn A, Waltmann A, Kattenberg E, et al. Identification of the asymptomatic Plasmodium falciparum and Plasmodium vivax gametocyte reservoir under different transmission intensities. PLoS Negl Trop Dis. 2021;15: e0009672.","journal-title":"PLoS Negl Trop Dis"},{"key":"5279_CR9","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2217\/fmb.11.108","volume":"6","author":"Z Liu","year":"2011","unstructured":"Liu Z, Miao J, Cui L. Gametocytogenesis in malaria parasite: commitment, development and regulation. Future Microbiol. 2011;6:1351\u201369.","journal-title":"Future Microbiol"},{"key":"5279_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/femsre\/fuz010","volume":"43","author":"P Ngotho","year":"2019","unstructured":"Ngotho P, Soares AB, Hentzschel F, Achcar F, Bertuccini L, Marti M. Revisiting gametocyte biology in malaria parasites. FEMS Microbiol Rev. 2019;43:401\u201314.","journal-title":"FEMS Microbiol Rev"},{"key":"5279_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12936-020-03559-0","volume":"20","author":"P Sondo","year":"2021","unstructured":"Sondo P, Bihoun B, Tahita MC, Derra K, Rouamba T, Nakanabo Diallo S, et al. Plasmodium falciparum gametocyte carriage in symptomatic patients shows significant association with genetically diverse infections, anaemia, and asexual stage density. Malar J. 2021;20:31.","journal-title":"Malar J"},{"key":"5279_CR12","doi-asserted-by":"publisher","first-page":"e0284751","DOI":"10.1371\/journal.pone.0284751","volume":"18","author":"NB Henry","year":"2023","unstructured":"Henry NB, Soulama I, Serm\u00e9 S, Bolscher JM, Huijs TG, Coulibaly AS, et al. Assessment of the transmission blocking activity of antimalarial compounds by membrane feeding assays using natural Plasmodium falciparum gametocyte isolates from West-Africa. PLoS ONE. 2023;18:e0284751.","journal-title":"PLoS ONE"},{"key":"5279_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.820650","volume":"12","author":"S Yu","year":"2022","unstructured":"Yu S, Wang J, Luo X, Zheng H, Wang L, Yang X, et al. Transmission-blocking strategies against malaria parasites during their mosquito stages. Front Cell Infect Microbiol. 2022;12: 820650.","journal-title":"Front Cell Infect Microbiol"},{"key":"5279_CR14","first-page":"CD008152","volume":"2","author":"PM Graves","year":"2018","unstructured":"Graves PM, Choi L, Gelband H, Garner P. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission. Cochrane Database Syst Rev. 2018;2:CD008152.","journal-title":"Cochrane Database Syst Rev"},{"key":"5279_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1473-3099(12)70198-6","volume":"13","author":"NJ White","year":"2013","unstructured":"White NJ. Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis. 2013;13:175\u201381.","journal-title":"Lancet Infect Dis"},{"key":"5279_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168702","volume":"12","author":"JT Lin","year":"2017","unstructured":"Lin JT, Lon C, Spring MD, Sok S, Chann S, Ittiverakul M, et al. Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: an open-label randomized trial. PLoS ONE. 2017;12: e0168702.","journal-title":"PLoS ONE"},{"key":"5279_CR17","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/infdis\/jiaa498","volume":"225","author":"K Stepniewska","year":"2022","unstructured":"Stepniewska K, Humphreys GS, Gon\u00e7alves BP, Craig E, Gosling R, Gu\u00e9rin PJ, et al. Efficacy of single-dose primaquine with artemisinin combination therapy on Plasmodium falciparum gametocytes and transmission: an individual patient meta-analysis. J Infect Dis. 2022;225:1215\u201326.","journal-title":"J Infect Dis"},{"key":"5279_CR18","unstructured":"WHO: Guidelines for the treatment of malaria. World Health Organization; 2015."},{"key":"5279_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190272","volume":"13","author":"GJ Bastiaens","year":"2018","unstructured":"Bastiaens GJ, Tiono AB, Okebe J, Pett HE, Coulibaly SA, Goncalves BP, et al. Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: two open-label, randomized, safety trials. PLoS ONE. 2018;13: e0190272.","journal-title":"PLoS ONE"},{"key":"5279_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S1473-3099(15)00479-X","volume":"16","author":"A Dicko","year":"2016","unstructured":"Dicko A, Brown JM, Diawara H, Baber I, Mahamar A, Soumare HM, et al. Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial. Lancet Infect Dis. 2016;16:674\u201384.","journal-title":"Lancet Infect Dis"},{"key":"5279_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1473-3099(18)30044-6","volume":"18","author":"A Dicko","year":"2018","unstructured":"Dicko A, Roh ME, Diawara H, Mahamar A, Soumare HM, Lanke K, et al. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial. Lancet Infect Dis. 2018;18:627\u201339.","journal-title":"Lancet Infect Dis"},{"key":"5279_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12916-016-0581-y","volume":"14","author":"BP Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves BP, Tiono AB, Ou\u00e9draogo A, Guelb\u00e9ogo WM, Bradley J, Nebie I, et al. Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial. BMC Med. 2016;14:40.","journal-title":"BMC Med"},{"key":"5279_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12936-022-04100-1","volume":"21","author":"RO Mwaiswelo","year":"2022","unstructured":"Mwaiswelo RO, Ngasala B, Msolo D, Kweka E, Mmbando BP, M\u00e5rtensson A. A single low dose of primaquine is safe and sufficient to reduce transmission of Plasmodium falciparum gametocytes regardless of cytochrome P450 2D6 enzyme activity in Bagamoyo district. Tanzania Malar J. 2022;21:84.","journal-title":"Tanzania Malar J"},{"key":"5279_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ebiom.2016.10.032","volume":"13","author":"J Okebe","year":"2016","unstructured":"Okebe J, Bousema T, Affara M, Di Tanna GL, Dabira E, Gaye A, et al. The gametocytocidal efficacy of different single doses of primaquine with dihydroartemisinin-piperaquine in asymptomatic parasite carriers in The Gambia: a randomized controlled trial. EBioMedicine. 2016;13:348\u201355.","journal-title":"EBioMedicine"},{"key":"5279_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12936-019-2841-8","volume":"8","author":"J Raman","year":"2019","unstructured":"Raman J, Allen E, Workman L, Mabuza A, Swanepoel H, Malatje G, et al. Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial. Malar J. 2019;8:209.","journal-title":"Malar J"},{"key":"5279_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/infdis\/jix237","volume":"216","author":"W Stone","year":"2017","unstructured":"Stone W, Sawa P, Lanke K, Rijpma S, Oriango R, Nyaurah M, et al. A molecular assay to quantify male and female Plasmodium falciparum gametocytes: results from 2 randomized controlled trials using primaquine for gametocyte clearance. J Infect Dis. 2017;216:457\u201367.","journal-title":"J Infect Dis"},{"key":"5279_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/cid\/cix355","volume":"65","author":"RC Tine","year":"2017","unstructured":"Tine RC, Sylla K, Faye BT, Poirot E, Fall FB, Sow D, et al. Safety and efficacy of adding a single low dose of primaquine to the treatment of adult patients with Plasmodium falciparum malaria in Senegal, to reduce gametocyte carriage: a randomized controlled trial. Clin Infect Dis. 2017;65:535\u201343.","journal-title":"Clin Infect Dis"},{"key":"5279_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/cpt.2512","volume":"111","author":"P Chotsiri","year":"2022","unstructured":"Chotsiri P, Mahamar A, Hoglund RM, Koita F, Sanogo K, Diawara H, et al. Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity. Clin Pharmacol Ther. 2022;111:676\u201385.","journal-title":"Clin Pharmacol Ther"},{"key":"5279_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/1475-2875-13-483","volume":"13","author":"NJ White","year":"2014","unstructured":"White NJ, Ashley EA, Recht J, Delves MJ, Ruecker A, Smithuis FM, et al. Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria. Malar J. 2014;13:483.","journal-title":"Malar J"},{"key":"5279_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042821","volume":"7","author":"T Bousema","year":"2012","unstructured":"Bousema T, Dinglasan RR, Morlais I, Gouagna LC, van Warmerdam T, Awono-Ambene PH, et al. Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS ONE. 2012;7: e42821.","journal-title":"PLoS ONE"},{"key":"5279_CR31","unstructured":"FMoH. National malaria elimination roadmap. Ethiopia, Addis Ababa, 2017."},{"key":"5279_CR32","unstructured":"PMI. President\u2019s Malaria Initiative Ethiopia Malaria Operational Plan FY 2023. CDC; 2023."},{"key":"5279_CR33","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/jiy060","volume":"217","author":"A Vantaux","year":"2018","unstructured":"Vantaux A, Samreth R, Piv E, Khim N, Kim S, Berne L, et al. Contribution to malaria transmission of symptomatic and asymptomatic parasite carriers in Cambodia. J Infect Dis. 2018;217:1561\u20138.","journal-title":"J Infect Dis"},{"key":"5279_CR34","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030. Geneva: World Health Organization; 2015."},{"key":"5279_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13071-023-06088-2","volume":"17","author":"A Abossie","year":"2024","unstructured":"Abossie A, Demissew A, Getachew H, Tsegaye A, Degefa T, Habtamu K, et al. Higher outdoor mosquito density and Plasmodium infection rates in and around malaria index case households in low transmission settings of Ethiopia: implications for vector control. Parasit Vectors. 2024;17:53.","journal-title":"Parasit Vectors"},{"key":"5279_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12936-023-04762-5","volume":"22","author":"H Getachew","year":"2023","unstructured":"Getachew H, Demissew A, Abossie A, Habtamu K, Wang X, Zhong D, et al. Asymptomatic and submicroscopic malaria infections in sugar cane and rice development areas of Ethiopia. Malar J. 2023;22:341.","journal-title":"Malar J"},{"key":"5279_CR37","unstructured":"FMoH. National malaria guidelines, 4th Edn. Ethiopia, Addis Ababa, 2017."},{"key":"5279_CR38","unstructured":"FMoH. National malaria guidelines. Ethiopia, Addis Ababa, 2018."},{"key":"5279_CR39","unstructured":"WHO. Giemsa staining of malaria blood films. Geneva: World Health Organization; 2016."},{"key":"5279_CR40","unstructured":"WHO. Malaria parasite counting. Geneva: World Health Organization; 2016."},{"key":"5279_CR41","unstructured":"Ba EH, Baird JK, Barnwell J, Bell D, Carter J, Dhorda M, et al. Microscopy for the detection, identification and quantification of malaria parasites on stained thick and thin blood films in research settings: procedure: methods manual. Geneva: World Health Organization; 2015. Available from: https:\/\/tdr.who.int\/publications\/i\/item\/2015-04-28-microscopy-for-the-detection-identification-and-quantification-of-malaria-parasites-on-stained-thick-and-thin-blood-films-in-research-settings."},{"key":"5279_CR42","doi-asserted-by":"crossref","unstructured":"Wooden J, Kyes S, Sibley CH. PCR and strain identification in Plasmodium falciparum.Parasitol Today. 1993;9:303-5.","DOI":"10.1016\/0169-4758(93)90131-X"},{"key":"5279_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1475-2875-9-361","volume":"9","author":"A Rosanas-Urgell","year":"2010","unstructured":"Rosanas-Urgell A, Mueller D, Betuela I, Barnadas C, Iga J, Zimmerman PA, et al. Comparison of diagnostic methods for the detection and quantification of the four sympatric Plasmodium species in field samples from Papua New Guinea. Malar J. 2010;9:361.","journal-title":"Malar J"},{"key":"5279_CR44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.exppara.2008.12.012","volume":"121","author":"V Veron","year":"2009","unstructured":"Veron V, Simon S, Carme B. Multiplex real-time PCR detection of P. falciparum, P. vivax and P. malariae in human blood samples. Exp Parasitol. 2009;121:346\u201351.","journal-title":"Exp Parasitol"},{"key":"5279_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molbiopara.2015.03.006","volume":"199","author":"P Schneider","year":"2015","unstructured":"Schneider P, Reece SE, Van Schaijk BC, Bousema T, Lanke KH, Meaden CS, et al. Quantification of female and male Plasmodium falciparum gametocytes by reverse transcriptase quantitative PCR. Mol Biochem Parasitol. 2015;199:29\u201333.","journal-title":"Mol Biochem Parasitol"},{"key":"5279_CR46","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12936-017-2011-9","volume":"16","author":"W Graumans","year":"2017","unstructured":"Graumans W, Tadesse FG, Andolina C, van Gemert G-J, Teelen K, Lanke K, et al. Semi-high-throughput detection of Plasmodium falciparum and Plasmodium vivax oocysts in mosquitoes using bead-beating followed by circumsporozoite ELISA and quantitative PCR. Malar J. 2017;16:356.","journal-title":"Malar J"},{"key":"5279_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12936-021-03602-8","volume":"20","author":"Q Zubair","year":"2021","unstructured":"Zubair Q, Matthews H, Sougoufara S, Mujeeb F, Ashall S, Aboagye-Antwi F, et al. Bulk-up synchronization of successive larval cohorts of Anopheles gambiae and Anopheles coluzzii through temperature reduction at early larval stages: effect on emergence rate, body size and mating success. Malar J. 2021;20:67.","journal-title":"Malar J"},{"key":"5279_CR48","first-page":"16","volume":"4","author":"AL Ou\u00e9draogo","year":"2013","unstructured":"Ou\u00e9draogo AL, Guelb\u00e9ogo WM, Cohuet A, Morlais I, King JG, Gon\u00e7alves BP, et al. A protocol for membrane feeding assays to determine the infectiousness of P. falciparum naturally infected individuals to Anopheles gambiae. Malariaworld J. 2013;4:16.","journal-title":"Malariaworld J."},{"key":"5279_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40794-022-00185-3","volume":"8","author":"K Habtamu","year":"2022","unstructured":"Habtamu K, Petros B, Yan G. Plasmodium vivax: the potential obstacles it presents to malaria elimination and eradication. Trop Dis Travel Med Vaccines. 2022;8:27.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"5279_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12936-020-3121-3","volume":"19","author":"S Shekalaghe","year":"2020","unstructured":"Shekalaghe S, Mosha D, Hamad A, Mbaga TA, Mihayo M, Bousema T, et al. Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether\u2013lumefantrine. Malar J. 2020;19:34.","journal-title":"Malar J"},{"key":"5279_CR51","volume":"3","author":"W Stone","year":"2022","unstructured":"Stone W, Mahamar A, Smit MJ, Sanogo K, Sinaba Y, Niambele SM, et al. Single low-dose tafenoquine combined with dihydroartemisinin\u2013piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial. Lancet Microbe. 2022;3: e732.","journal-title":"Lancet Microbe"},{"key":"5279_CR52","doi-asserted-by":"crossref","unstructured":"Styka AN, Savitz DA. Assessment of long-term health effects of antimalarial drugs when used for prophylaxis. Washington (DC): National Academies Press (US). 2020.","DOI":"10.17226\/25688"},{"key":"5279_CR53","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/1475-2875-11-360","volume":"11","author":"AC Eziefula","year":"2012","unstructured":"Eziefula AC, Gosling R, Hwang J, Hsiang MS, Bousema T, Von Seidlein L, et al. Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J. 2012;11:360.","journal-title":"Malar J"},{"key":"5279_CR54","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/trstmh\/trab087","volume":"115","author":"A Ahmad","year":"2021","unstructured":"Ahmad A, Soumare HM, Camara MM, Jadama L, Gaye PM, Bittaye H, et al. Infectivity of patent Plasmodium falciparum gametocyte carriers to mosquitoes: establishing capacity to investigate the infectious reservoir of malaria in a low-transmission setting in The Gambia. Trans R Soc Trop Med Hyg. 2021;115:1462\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5279_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34463","volume":"7","author":"J Bradley","year":"2018","unstructured":"Bradley J, Stone W, Da DF, Morlais I, Dicko A, Cohuet A, et al. Predicting the likelihood and intensity of mosquito infection from sex specific Plasmodium falciparum gametocyte density. Elife. 2018;7: e34463.","journal-title":"Elife"},{"key":"5279_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005674","volume":"11","author":"E Rovira-Vallbona","year":"2017","unstructured":"Rovira-Vallbona E, Contreras-Mancilla JJ, Ramirez R, Guzm\u00e1n-Guzm\u00e1n M, Carrasco-Escobar G, Llanos-Cuentas A, et al. Predominance of asymptomatic and sub-microscopic infections characterizes the Plasmodium gametocyte reservoir in the Peruvian Amazon. PLoS Negl Trop Dis. 2017;11: e0005674.","journal-title":"PLoS Negl Trop Dis"},{"key":"5279_CR57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12916-016-0621-7","volume":"14","author":"WWARN Gametocyte Study Group","year":"2016","unstructured":"WWARN Gametocyte Study Group. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med. 2016;14:79.","journal-title":"BMC Med"},{"key":"5279_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12936-017-1731-1","volume":"16","author":"NJ White","year":"2017","unstructured":"White NJ. Malaria parasite clearance. Malar J. 2017;16:88.","journal-title":"Malar J"},{"key":"5279_CR59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/cid\/cix336","volume":"65","author":"MM Ippolito","year":"2017","unstructured":"Ippolito MM, Johnson J, Mullin C, Mallow C, Morgan N, Wallender E, et al. The relative effects of artemether-lumefantrine and non-artemisinin antimalarials on gametocyte carriage and transmission of Plasmodium falciparum: a systematic review and meta-analysis. Clin Infect Dis. 2017;65:486\u201394.","journal-title":"Clin Infect Dis"},{"key":"5279_CR60","doi-asserted-by":"publisher","first-page":"e02108","DOI":"10.1128\/AAC.02108-19","volume":"64","author":"A Vantaux","year":"2020","unstructured":"Vantaux A, Kim S, Piv E, Chy S, Berne L, Khim N, et al. Significant efficacy of a single low dose of primaquine compared to stand-alone artemisinin combination therapy in reducing gametocyte carriage in Cambodian patients with uncomplicated multidrug-resistant Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2020;64:e02108-e2119.","journal-title":"Antimicrob Agents Chemother"},{"key":"5279_CR61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12936-024-04991-2","volume":"23","author":"M Tesfaye","year":"2024","unstructured":"Tesfaye M, Assefa A, Hailgiorgis H, Gidey B, Mohammed H, Tollera G, et al. Therapeutic efficacy and safety of artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria treatment in Metehara, Central-east Ethiopia. Malar J. 2024;23:184.","journal-title":"Malar J"},{"key":"5279_CR62","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1016\/S2666-5247(21)00055-0","volume":"2","author":"C Whittaker","year":"2021","unstructured":"Whittaker C, Slater H, Nash R, Bousema T, Drakeley C, Ghani AC, et al. Global patterns of submicroscopic Plasmodium falciparum malaria infection: insights from a systematic review and meta-analysis of population surveys. Lancet Microbe. 2021;2:e366\u201374.","journal-title":"Lancet Microbe"},{"key":"5279_CR63","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4269\/ajtmh.2007.76.470","volume":"76","author":"P Schneider","year":"2007","unstructured":"Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, et al. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg. 2007;76:470\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"5279_CR64","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1365-3156.2007.01821.x","volume":"12","author":"SA Shekalaghe","year":"2007","unstructured":"Shekalaghe SA, Teun Bousema J, Kunei KK, Lushino P, Masokoto A, Wolters LR, et al. Submicroscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania. Trop Med Int Health. 2007;12:547\u201353.","journal-title":"Trop Med Int Health"},{"key":"5279_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/parasitologia2020011","volume":"2","author":"BA Munro","year":"2022","unstructured":"Munro BA, McMorran BJ. Antimalarial drug strategies to target Plasmodium gametocytes. Parasitologia. 2022;2:101\u201324.","journal-title":"Parasitologia"},{"key":"5279_CR66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.35246","volume":"7","author":"A Ross","year":"2018","unstructured":"Ross A, Brancucci NMB. On a mission to block transmission. Elife. 2018;7: e35246.","journal-title":"Elife"},{"key":"5279_CR67","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05279-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T11:07:20Z","timestamp":1742209640000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05279-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5279"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05279-9","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}